Oxaliplatin/5‐fluorouracil‐based adjuvant chemotherapy as a standard of care for colon cancer in clinical practice: Outcomes of the ACCElox registry

Publisher： John Wiley & Sons Inc

E-ISSN： 1743-7563|11|4|334-342

ISSN： 1743-7555

Source： ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol.11, Iss.4, 2015-12, pp. : 334-342

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thymidylate Synthase Expression in Normal Colonic Mucosa: A Predictive Marker of Toxicity in Colorectal Cancer Patients Receiving 5-Fluorouracil-Based Adjuvant Chemotherapy

By  

Oncology, Vol. 67, Iss. 2, 2004-10 ,pp. : 135-142

Karger

Access to resources Recommend Favorite

Adjuvant Chemotherapy in Stage III Colon Cancer with 5-Fluorouracil and Levamisole versus 5-Fluorouracil and Leucovorin

By  

Oncology Research and Treatment, Vol. 25, Iss. 5, 2002-11 ,pp. : 426-430

Karger

Access to resources Recommend Favorite

Pulmonary Fibrosis after Chemotherapy with Oxaliplatin and 5-Fluorouracil for Colorectal Cancer

By  

Oncology, Vol. 73, Iss. 3-4, 2008-04 ,pp. : 270-272

Karger

Access to resources Recommend Favorite

Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy

By  

Oncology, Vol. 90, Iss. 1, 2016-0 ,pp. : 36-42

Karger

Access to resources Recommend Favorite

5-Fluorouracil Leucovorin and Oxaliplatin (FOLFOX) in the Treatment of Metastatic Colon Cancer with Severe Liver Dysfunction

By  

Oncology, Vol. 67, Iss. 3-4, 2004-11 ,pp. : 222-224

Karger

Access to resources Recommend Favorite